XUAN DE LA TORRE: Open Payments
NPI 1487163200 · LUTZ, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,982 in 85 payments from 20 companies in 2025. Trend: 2023 $2,715 · 2024 $3,871 · 2025 $1,982
Food & beverage: $1,982
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $297 |
| GENZYME CORPORATION | 5 | $175 |
| Galderma Laboratories, L.P. | 6 | $163 |
| UCB, Inc. | 4 | $153 |
| Lilly USA, LLC | 6 | $136 |
| Kerecis Limited | 9 | $136 |
| Botanix SB Inc | 2 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $109 |
| PFIZER INC. | 5 | $95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $85 |
Products named: DUPIXENT, SKYRIZI, NEMLUVIO, Bimzelx, EBGLYSS, Kerecis SurgiClose, RINVOQ, SOFDRA.
Industry payments across FL — which companies pay providers there.
